{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:58:43Z","timestamp":1791305923665,"version":"4.3.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["contraceptionjournal.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.contraception.2017.01.001","type":"journal-article","created":{"date-parts":[[2017,1,11]],"date-time":"2017-01-11T09:45:56Z","timestamp":1484127956000},"page":"456-463","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Endogenous thrombin potential changes during the first cycle of oral contraceptive use"],"prefix":"10.1016","volume":"95","author":[{"given":"Carolyn L.","family":"Westhoff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm C.","family":"Pike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Cremers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Eisenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella","family":"Thomassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Rosing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2017.01.001_bb0005","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0010-7824(97)00119-4","article-title":"First-time use of newer oral contraceptives and the risk of venous thromboembolism","volume":"56","author":"Suissa","year":"1997","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2017.01.001_bb0010","first-page":"61","article-title":"Oral contraceptives and risk of venous thromboembolism: impact of duration of use","volume":"57","author":"Farley","year":"1998","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2017.01.001_bb0015","doi-asserted-by":"crossref","first-page":"b2921","DOI":"10.1136\/bmj.b2921","article-title":"The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case\u2013control study","volume":"339","author":"van Hylckama Vlieg","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2017.01.001_bb0020","doi-asserted-by":"crossref","first-page":"h2135","DOI":"10.1136\/bmj.h2135","article-title":"Use of combined oral contraceptives and risk of venous thromboembolism: nested case\u2013control studies using the QResearch and CPRD databases","volume":"350","author":"Vinogradova","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2017.01.001_bb0025","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1046\/j.1365-2141.1997.192707.x","article-title":"Oral contraceptives and venous thrombosis: different sensitivities to activated protein C in women using second- and third-generation oral contraceptives","volume":"97","author":"Rosing","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.contraception.2017.01.001_bb0030","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1160\/TH06-09-0540","article-title":"Rapid activation of haemostasis after hormonal emergency contraception","volume":"97","author":"van Rooijen","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.contraception.2017.01.001_bb0035","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1055\/s-0037-1615216","article-title":"Hemostatic effects of oral contraceptives in women who developed deep-vein thrombosis while using oral contraceptives","volume":"80","author":"Bloemenkamp","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.contraception.2017.01.001_bb0040","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0010-7824(02)00476-6","article-title":"The effects of seven monophasic oral contraceptive regimens on hemostatic variables: conclusions from a large randomized multicenter study","volume":"67","author":"The Oral Contraceptive and Hemostasis Study Group","year":"2003","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2017.01.001_bb0045","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1182\/blood-2002-05-1416","article-title":"Fibrin fragment D-dimer and the risk of future venous thrombosis","volume":"101","author":"Cushman","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.contraception.2017.01.001_bb0050","doi-asserted-by":"crossref","first-page":"481","DOI":"10.7326\/0003-4819-149-7-200810070-00008","article-title":"Systematic review: D-dimer to predict recurrent disease after stopping anticoagulant therapy for unprovoked venous thromboembolism","volume":"149","author":"Verhovsek","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.contraception.2017.01.001_bb0055","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1055\/s-0037-1614323","article-title":"Venous thrombosis, oral contraceptives and high factor VIII levels","volume":"82","author":"Bloemenkamp","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.contraception.2017.01.001_bb0060","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/00001721-199910000-00002","article-title":"Influence of factor VIII\/von Willebrand complex on the activated protein C-resistance phenotype and on the risk for venous thromboembolism in heterozygous carriers of the factor V Leiden mutation","volume":"10","author":"De Mitrio","year":"1999","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.contraception.2017.01.001_bb0065","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1055\/s-0037-1613747","article-title":"High plasma concentration of factor VIIIc is a major risk factor for venous thromboembolism","volume":"83","author":"Kraaijenhagen","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.contraception.2017.01.001_bb0070","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.contraception.2015.09.015","article-title":"Clotting factor changes during the first cycle of oral contraceptive use","volume":"93","author":"Westhoff","year":"2016","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2017.01.001_bb0075","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000073575","article-title":"The Calibrated Automated Thrombogram (CAT): a universal routine test for hyper- and hypo-coagulability","volume":"32","author":"Hemker","year":"2002","journal-title":"Pathophysiol Haemost Thromb"},{"key":"10.1016\/j.contraception.2017.01.001_bb0080","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1001\/jama.296.4.397","article-title":"Identification of patients at low risk of recurrent venous thromboembolism by measuring thrombin generation","volume":"296","author":"Hron","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.contraception.2017.01.001_bb0085","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1111\/j.1538-7836.2008.03117.x","article-title":"High rate of unprovoked recurrent venous thrombosis is associated with high thrombin-generating potential in a prospective cohort study","volume":"6","author":"Besser","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.contraception.2017.01.001_bb0090","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1373\/clinchem.2008.112243","article-title":"Prediction of recurrent venous thromboembolism by endogenous thrombin potential and D-dimer","volume":"54","author":"Eichinger","year":"2008","journal-title":"Clin Chem"},{"key":"10.1016\/j.contraception.2017.01.001_bb0095","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1160\/TH08-02-0099","article-title":"Thrombin generation in patients after acute deep-vein thrombosis","volume":"100","author":"ten Cate-Hoek","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.contraception.2017.01.001_bb0100","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1111\/j.1538-7836.2008.03018.x","article-title":"High thrombin generation measured in the presence of thrombomodulin is associated with an increased risk of recurrent venous thromboembolism","volume":"6","author":"Tripodi","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.contraception.2017.01.001_bb0105","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1111\/j.1538-7836.2009.03561.x","article-title":"Peak thrombin generation and subsequent venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE) study","volume":"7","author":"Lutsey","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.contraception.2017.01.001_bb0110","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1055\/s-0038-1649707","article-title":"The influence of oral contraceptives on the time-integral of thrombin generation (thrombin potential)","volume":"70","author":"Rotteveel","year":"1993","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.contraception.2017.01.001_bb0115","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1046\/j.1365-2141.2003.04443.x","article-title":"Activated protein C resistance determined with a thrombin generation-based test predicts for venous thrombosis in men and women","volume":"122","author":"Tans","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.contraception.2017.01.001_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-0038-1657202","article-title":"Protein C deficiency in a Dutch family with thrombotic disease","volume":"48","author":"Bertina","year":"1982","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.contraception.2017.01.001_bb0125","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1172\/JCI111632","article-title":"Familial protein S deficiency is associated with recurrent thrombosis","volume":"74","author":"Comp","year":"1984","journal-title":"J Clin Invest"},{"key":"10.1016\/j.contraception.2017.01.001_bb0130","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1182\/blood.V64.6.1297.1297","article-title":"Plasma protein S deficiency in familial thrombotic disease","volume":"64","author":"Schwarz","year":"1984","journal-title":"Blood"},{"key":"10.1016\/j.contraception.2017.01.001_bb0135","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1073\/pnas.90.3.1004","article-title":"Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C","volume":"90","author":"Dahlb\u00e4ck","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.contraception.2017.01.001_bb0140","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1055\/s-0038-1642720","article-title":"Resistance to activated protein C and factor V Leiden as risk factors for venous thrombosis","volume":"74","author":"Bertina","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.contraception.2017.01.001_bb0145","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1182\/blood.V93.4.1271","article-title":"A reduced sensitivity for activated protein C in the absence of factor V Leiden increases the risk of venous thrombosis","volume":"93","author":"de Visser","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.contraception.2017.01.001_bb0150","doi-asserted-by":"crossref","first-page":"643","DOI":"10.7326\/0003-4819-130-8-199904200-00004","article-title":"Activated protein C resistance and factor V Leiden mutation are independent risk factors for venous thromboembolism","volume":"130","author":"Rodeghiero","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.contraception.2017.01.001_bb0155","doi-asserted-by":"crossref","first-page":"S375","DOI":"10.1016\/S0002-9378(99)70699-X","article-title":"Effects of oral contraceptives on hemastasis and thrombosis","volume":"180","author":"Rosing","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2017.01.001_bb0160","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/oxfordjournals.aje.a115799","article-title":"Oral contraceptive estrogen dose and the risk of deep venous thromboembolic disease","volume":"133","author":"Gerstman","year":"1991","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.contraception.2017.01.001_bb0165","doi-asserted-by":"crossref","first-page":"d6423","DOI":"10.1136\/bmj.d6423","article-title":"Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9","volume":"343","author":"Lidegaard","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2017.01.001_bb0170","doi-asserted-by":"crossref","first-page":"614.e1","DOI":"10.1016\/j.ajog.2014.12.007","article-title":"Estimating systemic exposure to ethinyl estradiol from an oral contraceptive","volume":"212","author":"Westhoff","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2017.01.001_bb0175","series-title":"Reproductive health and research","first-page":"15","article-title":"Medical eligibility criteria for contraceptive use","author":"World Health Organization","year":"2010"},{"key":"10.1016\/j.contraception.2017.01.001_bb0180","doi-asserted-by":"crossref","first-page":"3624","DOI":"10.1182\/blood-2004-03-1146","article-title":"Inhibition of thrombin generation by protein S at low procoagulant stimuli: implications for maintenance of the hemostatic balance","volume":"104","author":"Ser\u00e9","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.contraception.2017.01.001_bb0185","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1159\/000071636","article-title":"Calibrated automated thrombin generation measurement in clotting plasma","volume":"33","author":"Hemker","year":"2003","journal-title":"Pathophysiol Haemost Thromb"},{"key":"10.1016\/j.contraception.2017.01.001_bb0190","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.contraception.2012.06.003","article-title":"Using changes in binding globulins to assess oral contraceptive compliance","volume":"87","author":"Westhoff","year":"2013","journal-title":"Contraception"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782417300033?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782417300033?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,28]],"date-time":"2020-09-28T21:35:19Z","timestamp":1601328919000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782417300033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S0010782417300033"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2017.01.001","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endogenous thrombin potential changes during the first cycle of oral contraceptive use","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2017.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}